Eve & Co Announces Results of Annual & Special Meeting
June 26 2020 - 9:50AM
Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V:
EVE; OTCQX: EEVVF) announces the results of its 2020 Annual and
Special Meeting (“AGM”) of shareholders held virtually on Thursday,
June 25, 2020.
Shareholders approved all the resolutions
detailed in the management information circular of the Company
dated May 11, 2020 (the “Circular”), namely:
- Electing all the nominees to the Board of Directors of the
Company;
- Re-appointing Davidson & Company LLP as auditor of the
Company for the ensuing year and authorizing the directors to
determine the auditor’s compensation;
- Approving the Company’s stock option plan for the ensuing year
in accordance with the requirements of the TSX Venture
Requirements; and
- Approving a special resolution providing the Company’s
directors with the ability - but not requirement - to consolidate
the Company’s common shares at a time and in such circumstances as
may be later determined.
A total of 107,447,072 common shares of the
Company were voted at the AGM, representing approximately 37.32% of
the issued and outstanding common shares of the Company, with the
following results:
|
Votes |
|
For |
% |
Withheld |
% |
Total |
Yasir Naqvi as Director |
104,228,699 |
97.00% |
3,218,373 |
3.00% |
107,447,072 |
Ravi Sood as Director |
94,975,268 |
88.39% |
12,471,804 |
11.61% |
107,447,072 |
Melinda Rombouts as Director |
103,355,607 |
96.19% |
4,091,465 |
3.81% |
107,447,072 |
Appointment of Auditor |
114,182,333 |
98.82% |
1,368,585 |
1.18% |
115,550,918 |
Approval of Stock Option Plan |
97,372,578 |
90.62% |
10,074,494 |
9.38% |
107,447,072 |
Proposed Share Consolidation |
89,885,848 |
83.66% |
17,561,224 |
16.34% |
107,447,072 |
|
|
|
|
|
|
Following the AGM, the board of directors of the
Company confirmed the results of the AGM.
About Eve & Co
Incorporated
Eve & Co, through its wholly-owned
subsidiary Natural MedCo Ltd., holds cultivation and processing
licences under the Cannabis Act (Canada) for the production and
sale of various cannabis products, including dried cannabis,
cannabis plants and extraction of cannabis oil and has received its
European Union certificate of Good Manufacturing Practice. Natural
MedCo Ltd. was Canada’s first female-founded licensed producer of
medicinal marijuana and received its cultivation licence from
Health Canada in 2016. Eve & Co is led by a team of
agricultural experts and has a licensed 1,000,000 square foot
greenhouse located in Strathroy, Ontario.
The Company’s website can be visited at
www.evecannabis.ca.
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Notice regarding forward looking
statements:
Certain statements in this press release
constitute forward-looking information. All statements other than
statements of historical fact contained in this press release,
including, without limitation, those regarding the Company’s
expected sales to the Canadian medical cannabis markets,
opportunities for growth, future, strategy, plans, objectives,
goals and targets, and any statements preceded by, followed by or
that include the words “believe”, “expect”, “aim”, “intend”,
“plan”, “continue”, “will”, “may”, “would”, “anticipate”,
“estimate”, “forecast”, “predict”, “project”, “seek”, “should” or
similar expressions or the negative thereof, are forward-looking
statements. These statements are not historical facts but instead
represent only the Company’s expectations, estimates and
projections regarding future events. These statements are not
guarantees of future performance and involve assumptions, risks and
uncertainties that are difficult to predict, including those
described in the Company’s management’s discussion and analysis for
the three month period ended March 31, 2020 which is available on
the Company’s SEDAR profile. Therefore, actual results may differ
materially from what is expressed, implied or forecasted in such
forward-looking statements. The forward-looking information and
forward-looking statements included in this news release are made
as of the date of this news release. The Company does not undertake
an obligation to publicly update such forward-looking information
or forward-looking information to reflect new information,
subsequent events or otherwise unless required by applicable
securities law.
For further information, please
contact: Melinda Rombouts President and Chief Executive
Officer Eve & Co Incorporated Telephone: (855) 628-6337
Eve & (TSXV:EVE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eve & (TSXV:EVE)
Historical Stock Chart
From Jul 2023 to Jul 2024